![](/img/cover-not-exists.png)
A Prospective Phase II Clinical Trial of CD26/Dipeptidyl Peptidase (DPP)-IV Inhibition for Prevention of Acute Graft Versus Host Disease (aGVHD) Following Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation.
Farag, Sherif S, Zaid, Mohammad Abu, Nelson, Robert P, Schwartz, Jennifer E, Thakrar, Teresa C, Huntley, Carol, Blakley, Anne J, Abonour, Rafat, Robertson, Michael J, Zhang, ShuhongVolume:
26
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2019.12.096
Date:
March, 2020
File:
PDF, 153 KB
2020